MedPath

Exercise and Diabetes - an Observational Study of Exercise and Blood Glucose Control

Completed
Conditions
Type 1 Diabetes
Type 2 Diabetes
Interventions
Other: exercise
Registration Number
NCT02190669
Lead Sponsor
Sansum Diabetes Research Institute
Brief Summary

This proposal seeks to gather continuous blood glucose and physical activity data from individuals with and without diabetes.

Detailed Description

This proposal seeks to gather continuous blood glucose and physical activity data from individuals with and without diabetes who are physically active and exercising for health benefits. The investigators hypothesize that insulin requirements will be inversely related to intensity of activity and an algorithm will be able to detect physical activity and automatically adjust insulin doses. Once such an algorithm has been determined for an individual, it can be applied to future similar situations, but ideally the algorithm will be dynamically refined based on closed-loop feedback information.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Inclusion criteria for subjects with diabetes
  • Type 1 diabetes or insulin requiring type 2 diabetes for at least 1 year
  • Use insulin to control diabetes
  • Physically active (regularly work out, swim, run, walk, bike, etc.)
  • Free of major micro- and macrovascular complications of diabetes
  • 18-75 years of age
  • A1C < 9.0% Inclusion criteria for subjects without diabetes
  • No evidence of diabetes and physically active
Exclusion Criteria
  • unwilling to perform repeated glucose checks or take insulin as instructed
  • abnormal thyroid function, kidney function, liver function
  • pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
exercise in individuals without diabetesexerciseexercise in individuals without diabetes
exercise in type 1 diabetesexerciseexercise in type 1 diabetes
exercise in type 2 diabetesexerciseexercise in type 2 diabetes
Primary Outcome Measures
NameTimeMethod
Document the glycemic response of individuals without diabetes and with type 1 or type 2 diabetes7 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sansum Diabetes Research Institute

🇺🇸

Santa Barbara, California, United States

© Copyright 2025. All Rights Reserved by MedPath